🇺🇸 FDA
Company

MIRA

MIRA PHARMACEUTICALS, INC.

MIRA pharma USA

Quick answer

MIRA is a pharma company (MIRA) headquartered in MIAMI, FL, USA with 1 tracked pipeline programs.

Pipeline (1)

project

Toujeo

Diabetes Mellitus, Type 2

Approved · small_molecule · completed

1 trials

Drugs (7)

drug

azelaic acid

AZELAIC ACID

 drug

flurandrenolide

CORDRAN N

 drug

mequinol

SOLAGE

 drug

retapamulin

ALTABAX

 drug

sarecycline hydrochloride

SEYSARA

 drug

tazarotene

TAZAROTENE

 drug

tirbanibulin

KLISYRI

Patents (8)

patent

US 12421228

Naphthyridine derivatives as PRC2 inhibitors

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12421253

Tetrahydropyridopyrimidine pan-KRas inhibitors

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12414911

Topical compositions and methods of use

Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12412764

Substrate-accommodating container

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12398154

Azaquinazoline pan-KRas inhibitors

Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12383503

Adagrasib solid pharmaceutical compositions

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12377101

Combination therapies

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12371435

Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)